132 related articles for article (PubMed ID: 6708755)
1. Increased lysolecithin acyltransferase activity in the plasma of type II hyperlipoproteinemic patients.
Subbaiah PV; Ogilvie JT
Lipids; 1984 Feb; 19(2):80-4. PubMed ID: 6708755
[TBL] [Abstract][Full Text] [Related]
2. Requirement of low density lipoproteins for the lysolecithin acyl transferase activity in human plasma: assay of enzyme activity in abetalipoproteinemic patients.
Subbaiah PV
Metabolism; 1982 Mar; 31(3):294-8. PubMed ID: 7078415
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.
Sestak TL; Alavi N; Subbaiah PV
Kidney Int; 1989 Aug; 36(2):240-8. PubMed ID: 2779094
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase.
Subbaiah PV; Albers JJ; Chen CH; Bagdade JD
J Biol Chem; 1980 Oct; 255(19):9275-80. PubMed ID: 7410425
[TBL] [Abstract][Full Text] [Related]
5. Molecular species of phosphatidylcholine in abetalipoproteinemia: effect of lecithin:cholesterol acyltransferase and lysolecithin acyltransferase.
Banerji B; Subbaiah PV; Gregg RE; Bagdade JD
J Lipid Res; 1989 Dec; 30(12):1907-16. PubMed ID: 2621418
[TBL] [Abstract][Full Text] [Related]
6. Lecithin: cholesterol acyltransferase activity in dialyzed and undialyzed chronic uremic patients.
Bories PC; Subbaiah PV; Bagdade JD
Nephron; 1982; 32(1):22-7. PubMed ID: 7177273
[TBL] [Abstract][Full Text] [Related]
7. Effect of apoprotein B conformation on the activation of lysolecithin acyltransferase and lecithin: cholesterol acyltransferase. Studies with subfractions of low density lipoproteins.
Liu M; Krul ES; Subbaiah PV
J Biol Chem; 1992 Mar; 267(8):5139-47. PubMed ID: 1544896
[TBL] [Abstract][Full Text] [Related]
8. Role of low density lipoprotein in the activation of plasma lysolecithin acyltransferase activity. Effect of chemical and enzymatic modifications of the lipoprotein on enzyme activity.
Subbaiah PV; Chen CH; Bagdade JD; Albers JJ
Atherosclerosis; 1985 Jan; 54(1):99-110. PubMed ID: 3922384
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction.
Subbaiah PV; Chen CH; Bagdade JD; Albers JJ
J Biol Chem; 1985 May; 260(9):5308-14. PubMed ID: 3988756
[TBL] [Abstract][Full Text] [Related]
10. Association of lysolecithin acyltransferase with the high density lipoproteins and its activation by the low density lipoproteins in normal human plasma.
Subbaiah PV; Bagdade JD
Biochim Biophys Acta; 1979 Apr; 573(1):212-7. PubMed ID: 222334
[TBL] [Abstract][Full Text] [Related]
11. Activation of plasma lysolecithin acyltransferase reaction by apolipoproteins A-I, C-I and E.
Liu M; Subbaiah PV
Biochim Biophys Acta; 1993 Jun; 1168(2):144-52. PubMed ID: 8504148
[TBL] [Abstract][Full Text] [Related]
12. Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome.
Subbaiah PV; Rodby RA
Metabolism; 1994 Sep; 43(9):1126-33. PubMed ID: 8084287
[TBL] [Abstract][Full Text] [Related]
13. Studies on the cofactor requirement for the acylation and hydrolysis reactions catalyzed by purified lecithin-cholesterol acyltransferase. Effect of low density lipoproteins and apolipoprotein A-i.
Subbaiah PV; Chen CH; Albers JJ; Bagdade JD
Atherosclerosis; 1982 Nov; 45(2):181-90. PubMed ID: 7159494
[TBL] [Abstract][Full Text] [Related]
14. Lecithin:cholesterol acyl transfer in plasma of normal persons in relation to lipid and lipoprotein concentration.
Wallentin L; Vikrot O
Scand J Clin Lab Invest; 1975 Nov; 35(7):669-76. PubMed ID: 174186
[TBL] [Abstract][Full Text] [Related]
15. Lecithin: cholesterol acyl transfer rate in plasma and its relation to lipid and lipoprotein concentrations in primary hyperlipidemia.
Wallentin L
Atherosclerosis; 1977 Feb; 26(2):233-48. PubMed ID: 189784
[TBL] [Abstract][Full Text] [Related]
16. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Sakane H; Nakamura H
Atherosclerosis; 1997 Mar; 129(2):241-8. PubMed ID: 9105567
[TBL] [Abstract][Full Text] [Related]
17. Lysolecithin acyltransferase of human plasma: assay and characterization of enzyme activity.
Subbaiah PV
Methods Enzymol; 1986; 129():790-7. PubMed ID: 3523164
[No Abstract] [Full Text] [Related]
18. Effect of heparin on lecithin: cholesterol acyltransferase and lipids in cholestasis.
Rubiés-Prat J; Ras MR; Frisón JC; Miquel C; Masdeu S; Bacardi R
Digestion; 1976; 14(3):250-5. PubMed ID: 955331
[TBL] [Abstract][Full Text] [Related]
19. Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.
Tani S; Takahashi A; Nagao K; Hirayama A
Heart Vessels; 2016 Jun; 31(6):831-40. PubMed ID: 25894629
[TBL] [Abstract][Full Text] [Related]
20. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
